99 related articles for article (PubMed ID: 33292123)
1. Molecular Descriptors of Some Chemicals that Prevent COVID-19.
Mondal S; De N; Pal A; Gao W
Curr Org Synth; 2021; 18(8):729-741. PubMed ID: 33292123
[TBL] [Abstract][Full Text] [Related]
2. A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2.
Mhatre S; Naik S; Patravale V
Comput Biol Med; 2021 Feb; 129():104137. PubMed ID: 33302163
[TBL] [Abstract][Full Text] [Related]
3. QSPR/QSAR analysis of some eccentricity based topological descriptors of antiviral drugs used in COVID-19 treatment via $ \mathscr{D}\varepsilon $- polynomials.
Sarkarai D; Desikan K
Math Biosci Eng; 2023 Sep; 20(9):17272-17295. PubMed ID: 37920055
[TBL] [Abstract][Full Text] [Related]
4. Topological indices and QSPR/QSAR analysis of some antiviral drugs being investigated for the treatment of COVID-19 patients.
Kirmani SAK; Ali P; Azam F
Int J Quantum Chem; 2021 May; 121(9):e26594. PubMed ID: 33612855
[TBL] [Abstract][Full Text] [Related]
5. Computation and Analysis of Topological Co-Indices for Metal-Organic Compound.
Zhao D; Muhammad MH; Siddiqui MK; Nasir M; Nadeem MF; Hanif MF
Curr Org Synth; 2021; 18(8):750-760. PubMed ID: 33719958
[TBL] [Abstract][Full Text] [Related]
6. Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships.
Ivanciuc O
Curr Comput Aided Drug Des; 2013 Jun; 9(2):153-63. PubMed ID: 23701000
[TBL] [Abstract][Full Text] [Related]
7. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
[TBL] [Abstract][Full Text] [Related]
8. Curvilinear regression analysis of benzenoid hydrocarbons and computation of some reduced reverse degree based topological indices for hyaluronic acid-paclitaxel conjugates.
Ravi V; Desikan K
Sci Rep; 2023 Feb; 13(1):3239. PubMed ID: 36828838
[TBL] [Abstract][Full Text] [Related]
9. Neighborhood degree sum-based molecular descriptors of fractal and Cayley tree dendrimers.
Mondal S; De N; Pal A
Eur Phys J Plus; 2021; 136(3):303. PubMed ID: 33717795
[TBL] [Abstract][Full Text] [Related]
10. Structure-property modeling of coumarins and coumarin-related compounds in pharmacotherapy of cancer by employing graphical topological indices.
Timmanaikar ST; Hayat S; Hosamani SM; Banu S
Eur Phys J E Soft Matter; 2024 May; 47(5):31. PubMed ID: 38735010
[TBL] [Abstract][Full Text] [Related]
11. On Certain Degree Based and Bond-additive Topological Indices of Dodeca-benzo-circumcorenene.
Gunasekar T; Kathavarayan P; Alsinai A; Murugan G
Comb Chem High Throughput Screen; 2024; 27(11):1629-1641. PubMed ID: 38213147
[TBL] [Abstract][Full Text] [Related]
12. Hydration-Induced Disorder Lowers the Energy Barriers for Methyl Rotation in Drug Molecules.
Mamontov E; Cheng Y; Daemen LL; Kolesnikov AI; Ramirez-Cuesta AJ; Ryder MR; Stone MB
J Phys Chem Lett; 2020 Dec; 11(23):10256-10261. PubMed ID: 33210927
[TBL] [Abstract][Full Text] [Related]
13. Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.
Ohgitani E; Shin-Ya M; Ichitani M; Kobayashi M; Takihara T; Kawamoto M; Kinugasa H; Mazda O
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208050
[TBL] [Abstract][Full Text] [Related]
14. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
15. Remdesivir: First Approval.
Lamb YN
Drugs; 2020 Sep; 80(13):1355-1363. PubMed ID: 32870481
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir.
Yin W; Mao C; Luan X; Shen DD; Shen Q; Su H; Wang X; Zhou F; Zhao W; Gao M; Chang S; Xie YC; Tian G; Jiang HW; Tao SC; Shen J; Jiang Y; Jiang H; Xu Y; Zhang S; Zhang Y; Xu HE
Science; 2020 Jun; 368(6498):1499-1504. PubMed ID: 32358203
[TBL] [Abstract][Full Text] [Related]
17. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
Sun D
AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
[TBL] [Abstract][Full Text] [Related]
18. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors.
Nandi S; Bagchi MC
Curr Comput Aided Drug Des; 2015; 11(2):184-93. PubMed ID: 26135340
[TBL] [Abstract][Full Text] [Related]
19. Uncertainty about the Efficacy of Remdesivir on COVID-19.
Yoo JH
J Korean Med Sci; 2020 Jun; 35(23):e221. PubMed ID: 32537956
[No Abstract] [Full Text] [Related]
20. Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir.
Gordon CJ; Lee HW; Tchesnokov EP; Perry JK; Feng JY; Bilello JP; Porter DP; Götte M
J Biol Chem; 2022 Feb; 298(2):101529. PubMed ID: 34953856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
